BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23632240)

  • 1. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
    Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
    Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
    J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
    Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
    Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
    Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
    Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
    Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
    Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
    Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
    Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis.
    Jia F; Sun R; Li J; Li Q; Chen G; Fu W
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):398-401. PubMed ID: 27227383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
    Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
    Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
    Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
    Bi J; Zhong C; Li K; Chu H; Wang B
    Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
    Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
    Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
    Gao LB; Li LJ; Pan XM; Li ZH; Liang WB; Bai P; Zhu YH; Zhang L
    Biol Chem; 2013 Mar; 394(3):415-20. PubMed ID: 23183747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TP53 rs1042522 G > C, MDM2 rs2279744 T > G, and miR-34b/c rs4938723 T > C polymorphisms with aneuploidy pregnancy susceptibility.
    Chan Y; Xu W; Feng Y; Zhang Y; Li S; Geng Z; Liu Z; Zhao Q; Zhang J; Zhu B
    BMC Pregnancy Childbirth; 2023 Aug; 23(1):624. PubMed ID: 37648962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
    Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
    World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
    Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
    Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pri-miR-34b/c rs4938723 polymorphism contributes to acute lymphoblastic leukemia susceptibility in Chinese children.
    Tong N; Chu H; Wang M; Xue Y; Du M; Lu L; Zhang H; Wang F; Fang Y; Li J; Wu D; Zhang Z; Sheng X
    Leuk Lymphoma; 2016; 57(6):1436-41. PubMed ID: 26380954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.